Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

A modified spectrogram with possible application as a visual hearing aid for the deaf.

Hillier AF, Hillier CE, Hillier DA.

J Acoust Soc Am. 2018 Sep;144(3):1517. doi: 10.1121/1.5055224.

PMID:
30424670
2.

Perceived preparedness for full-scope pharmacist services among recent Doctor of Pharmacy graduates from Ontario schools of pharmacy.

Waite NM, McCarthy L, Milne E, Hillier C, Houle SKD, Dolovich L.

J Am Pharm Assoc (2003). 2018 Nov - Dec;58(6):630-637. doi: 10.1016/j.japh.2018.06.016. Epub 2018 Aug 1.

PMID:
30077565
3.

Neural scene representation and rendering.

Eslami SMA, Jimenez Rezende D, Besse F, Viola F, Morcos AS, Garnelo M, Ruderman A, Rusu AA, Danihelka I, Gregor K, Reichert DP, Buesing L, Weber T, Vinyals O, Rosenbaum D, Rabinowitz N, King H, Hillier C, Botvinick M, Wierstra D, Kavukcuoglu K, Hassabis D.

Science. 2018 Jun 15;360(6394):1204-1210. doi: 10.1126/science.aar6170.

PMID:
29903970
4.

Detecting malnutrition risk and obesity after spinal cord injury: a quality improvement project and systematic review.

Wong S, Kenssous N, Hillier C, Pollmer S, Jackson P, Lewis S, Saif M.

Eur J Clin Nutr. 2018 Nov;72(11):1555-1560. doi: 10.1038/s41430-018-0194-y. Epub 2018 May 30.

PMID:
29849183
5.

The implementation of medical revalidation: an assessment using normalisation process theory.

Tazzyman A, Ferguson J, Hillier C, Boyd A, Tredinnick-Rowe J, Archer J, de Bere SR, Walshe K.

BMC Health Serv Res. 2017 Nov 21;17(1):749. doi: 10.1186/s12913-017-2710-5.

6.

The Evolving Purposes of Medical Revalidation in the United Kingdom: A Qualitative Study of Professional and Regulatory Narratives.

Tazzyman A, Ferguson J, Walshe K, Boyd A, Tredinnick-Rowe J, Hillier C, Regan De Bere S, Archer J.

Acad Med. 2018 Apr;93(4):642-647. doi: 10.1097/ACM.0000000000001993.

7.

Mii-vitaliSe: a pilot randomised controlled trial of a home gaming system (Nintendo Wii) to increase activity levels, vitality and well-being in people with multiple sclerosis.

Thomas S, Fazakarley L, Thomas PW, Collyer S, Brenton S, Perring S, Scott R, Thomas F, Thomas C, Jones K, Hickson J, Hillier C.

BMJ Open. 2017 Sep 27;7(9):e016966. doi: 10.1136/bmjopen-2017-016966.

8.

Mkit: A cell migration assay based on microfluidic device and smartphone.

Yang K, Wu J, Peretz-Soroka H, Zhu L, Li Z, Sang Y, Hipolito J, Zhang M, Santos S, Hillier C, de Faria RL, Liu Y, Lin F.

Biosens Bioelectron. 2018 Jan 15;99:259-267. doi: 10.1016/j.bios.2017.07.064. Epub 2017 Jul 27.

9.

Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).

Thomas S, Kersten P, Thomas PW, Slingsby V, Nock A, Jones R, Davies Smith A, Galvin KT, Baker R, Hillier C.

BMJ Open. 2015 Oct 20;5(10):e008274. doi: 10.1136/bmjopen-2015-008274.

10.

A Microfluidic Platform for Evaluating Neutrophil Chemotaxis Induced by Sputum from COPD Patients.

Wu J, Hillier C, Komenda P, Lobato de Faria R, Levin D, Zhang M, Lin F.

PLoS One. 2015 May 11;10(5):e0126523. doi: 10.1371/journal.pone.0126523. eCollection 2015.

11.

Chimpshop and alcohol reduction - using technology to change behaviour.

Cox M, Intrilligator J, Hillier C.

Perspect Public Health. 2015 May;135(3):126-7. doi: 10.1177/1757913915580926. No abstract available.

PMID:
25925306
12.

Opportunistic infections of the retina in patients with aquaporin-4 antibody disease.

George JS, Leite MI, Kitley JL, Jones N, Cortes N, Donati M, Matthews BN, Calladine D, Hillier C, Yusuf IH, Munneke R, Patel CK, Palace JA, Elston JS.

JAMA Neurol. 2014 Nov;71(11):1429-32. doi: 10.1001/jamaneurol.2014.1620.

PMID:
25199567
13.

One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.

Thomas PW, Thomas S, Kersten P, Jones R, Slingsby V, Nock A, Davies Smith A, Baker R, Galvin KT, Hillier C.

BMC Neurol. 2014 May 19;14:109. doi: 10.1186/1471-2377-14-109.

14.

Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.

Thomas S, Fazakarley L, Thomas PW, Brenton S, Collyer S, Perring S, Scott R, Galvin K, Hillier C.

BMJ Open. 2014 May 7;4(5):e005172. doi: 10.1136/bmjopen-2014-005172.

15.

Regulatory authority approaches to deploying quality improvement standards to community pharmacies: insights from the SafetyNET-RX program.

Boyle TA, Bishop AC, Hillier C, Mahaffey T, MacKinnon NJ, Zwicker B.

J Pharm Pract. 2014 Apr;27(2):138-49. doi: 10.1177/0897190013508138. Epub 2013 Oct 22.

PMID:
24150487
16.

Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.

Dalzell JR, Seed A, Berry C, Whelan CJ, Petrie MC, Padmanabhan N, Clarke A, Biggerstaff F, Hillier C, McMurray JJ.

Cardiovasc Ther. 2014 Feb;32(1):13-8. doi: 10.1111/1755-5922.12053.

PMID:
24138103
17.

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC), Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofontos A, Hakonarson H, Halfpenny C, Hall G, Hall P, Hamsten A, Harley J, Harrower T, Hawkins C, Hellenthal G, Hillier C, Hobart J, Hoshi M, Hunt SE, Jagodic M, Jelčić I, Jochim A, Kendall B, Kermode A, Kilpatrick T, Koivisto K, Konidari I, Korn T, Kronsbein H, Langford C, Larsson M, Lathrop M, Lebrun-Frenay C, Lechner-Scott J, Lee MH, Leone MA, Leppä V, Liberatore G, Lie BA, Lill CM, Lindén M, Link J, Luessi F, Lycke J, Macciardi F, Männistö S, Manrique CP, Martin R, Martinelli V, Mason D, Mazibrada G, McCabe C, Mero IL, Mescheriakova J, Moutsianas L, Myhr KM, Nagels G, Nicholas R, Nilsson P, Piehl F, Pirinen M, Price SE, Quach H, Reunanen M, Robberecht W, Robertson NP, Rodegher M, Rog D, Salvetti M, Schnetz-Boutaud NC, Sellebjerg F, Selter RC, Schaefer C, Shaunak S, Shen L, Shields S, Siffrin V, Slee M, Sorensen PS, Sorosina M, Sospedra M, Spurkland A, Strange A, Sundqvist E, Thijs V, Thorpe J, Ticca A, Tienari P, van Duijn C, Visser EM, Vucic S, Westerlind H, Wiley JS, Wilkins A, Wilson JF, Winkelmann J, Zajicek J, Zindler E, Haines JL, Pericak-Vance MA, Ivinson AJ, Stewart G, Hafler D, Hauser SL, Compston A, McVean G, De Jager P, Sawcer SJ, McCauley JL.

Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29.

18.

A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.

Thomas S, Thomas PW, Kersten P, Jones R, Green C, Nock A, Slingsby V, Smith AD, Baker R, Galvin KT, Hillier C.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1092-9. doi: 10.1136/jnnp-2012-303816. Epub 2013 May 21.

19.

Short-term incubation of equine laminar veins with cortisol and insulin alters contractility in vitro: possible implications for the pathogenesis of equine laminitis.

Keen JA, McGorum BC, Hillier C, Nally JE.

J Vet Pharmacol Ther. 2013 Aug;36(4):382-8. doi: 10.1111/j.1365-2885.2012.01429.x. Epub 2012 Sep 3.

PMID:
22943152
20.

The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans.

Seed A, Kuc RE, Maguire JJ, Hillier C, Johnston F, Essers H, de Voogd HJ, McMurray J, Davenport AP.

Life Sci. 2012 Oct 15;91(13-14):743-8. doi: 10.1016/j.lfs.2012.03.022. Epub 2012 Mar 28.

21.

Safety of medicine and the use of animals in research.

Archibald K, Baxter AD, BéruBé K, Bunton D, Clotworthy M, Coleman B, Foster CS, Hillier C, McFarlane M, Patel A, Pierscionek B, Root J, Thomas G, Tsaioun K, Wilkinson JM, Wilmut I, Wright KL.

Lancet. 2011 Oct 29;378(9802):e2. doi: 10.1016/S0140-6736(11)61669-3. No abstract available.

PMID:
22035557
22.

Decompensation of undiagnosed spinal dural arteriovenous fistulae after lumbar epidural injection and spinal anaesthesia.

Owen NC, Smith LT, Massey L, Durnford AJ, Hillier CE.

Br J Anaesth. 2011 Jul;107(1):109-11. doi: 10.1093/bja/aer179. No abstract available.

23.

Calpainopathy presenting as foot drop in a 41 year old.

Burke G, Hillier C, Cole J, Sampson M, Bridges L, Bushby K, Barresi R, Hammans SR.

Neuromuscul Disord. 2010 Jun;20(6):407-10. doi: 10.1016/j.nmd.2010.04.006.

PMID:
20580976
24.

Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis.

Thomas PW, Thomas S, Kersten P, Jones R, Nock A, Slingsby V, Green C, Baker R, Galvin K, Hillier C.

BMC Neurol. 2010 Jun 16;10:43. doi: 10.1186/1471-2377-10-43.

25.

Could fresh human tissues play a key role in drug development?

Hillier C, Bunton D.

Altern Lab Anim. 2009 Sep;37 Suppl 1:5-10.

PMID:
19807198
26.

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.

Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Heppner DG Jr.

Vaccine. 2010 Jul 12;28(31):5135-44. doi: 10.1016/j.vaccine.2009.08.046. Epub 2009 Sep 6.

PMID:
19737527
27.

Development and preliminary evaluation of a cognitive behavioural approach to fatigue management in people with multiple sclerosis.

Thomas S, Thomas PW, Nock A, Slingsby V, Galvin K, Baker R, Moffat N, Hillier C.

Patient Educ Couns. 2010 Feb;78(2):240-9. doi: 10.1016/j.pec.2009.07.001. Epub 2009 Aug 7.

PMID:
19665337
28.

ER-Golgi network--a future target for anti-cancer therapy.

Wlodkowic D, Skommer J, McGuinness D, Hillier C, Darzynkiewicz Z.

Leuk Res. 2009 Nov;33(11):1440-7. doi: 10.1016/j.leukres.2009.05.025. Review.

29.

Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs.

Collingwood MA, Rose SD, Huang L, Hillier C, Amarzguioui M, Wiiger MT, Soifer HS, Rossi JJ, Behlke MA.

Oligonucleotides. 2008 Jun;18(2):187-200. doi: 10.1089/oli.2008.0123.

30.

Endothelin mediated contraction of equine laminar veins.

Keen JA, Hillier C, McGorum BC, Nally JE.

Equine Vet J. 2008 Jul;40(5):488-92. doi: 10.2746/042516408X313634.

PMID:
18487099
31.

Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host.

Angov E, Hillier CJ, Kincaid RL, Lyon JA.

PLoS One. 2008 May 14;3(5):e2189. doi: 10.1371/journal.pone.0002189.

32.

Multiparameter detection of apoptosis using red-excitable SYTO probes.

Wlodkowic D, Skommer J, Hillier C, Darzynkiewicz Z.

Cytometry A. 2008 Jun;73(6):563-9. doi: 10.1002/cyto.a.20564.

33.

Evaluation of equine laminar vein function: harvesting, dissection and the use of functional methods to distinguish between veins and arteries.

Keen JA, Hillier C, McGorum BC, Bunton D, Nally JE.

J Pharmacol Toxicol Methods. 2008 Mar-Apr;57(2):92-9. doi: 10.1016/j.vascn.2007.10.005. Epub 2008 Jan 19.

PMID:
18280185
34.

Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.

Seed A, Gardner R, McMurray J, Hillier C, Murdoch D, MacFadyen R, Bobillier A, Mann J, McDonagh T.

Eur J Heart Fail. 2007 Nov;9(11):1120-7. Epub 2007 Oct 18.

35.

Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-activated potassium channels in essential hypertension.

Sainsbury CA, Coleman J, Brady AJ, Connell JM, Hillier C, Petrie JR.

J Hum Hypertens. 2007 Oct;21(10):808-14. Epub 2007 May 17.

PMID:
17508013
36.

Functional human tissue assays.

Hillier C, Bunton D.

Drug Discov Today. 2007 May;12(9-10):382-8. Epub 2007 Apr 5. Review.

PMID:
17467574
37.

Heel lifts and the stance phase of gait in subjects with limited ankle dorsiflexion.

Johanson MA, Cooksey A, Hillier C, Kobbeman H, Stambaugh A.

J Athl Train. 2006 Apr-Jun;41(2):159-65.

38.

The development and application of a diatom-based quantitative reconstruction technique in forensic science.

Horton BP, Boreham S, Hillier C.

J Forensic Sci. 2006 May;51(3):643-50.

PMID:
16696714
39.

Psychological interventions for multiple sclerosis.

Thomas PW, Thomas S, Hillier C, Galvin K, Baker R.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004431. Review.

PMID:
16437487
40.

Effects of oxidized and glycated low-density lipoproteins on transcription and secretion of plasminogen activator inhibitor-1 in vascular endothelial cells.

Ma GM, Halayko AJ, Stelmack GL, Zhu F, Zhao R, Hillier CT, Shen GX.

Cardiovasc Pathol. 2006 Jan-Feb;15(1):3-10.

PMID:
16414450
41.

Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes.

Kernohan AF, Spiers A, Sattar N, Hillier C, Cleland SJ, Small M, Lumsden MA, McConnell J, Petrie JR.

Diab Vasc Dis Res. 2004 Oct;1(2):82-8.

PMID:
16302646
42.

Evidence for involvement of alpha1D-adrenoceptors in contraction of femoral resistance arteries using knockout mice.

Zacharia J, Hillier C, Tanoue A, Tsujimoto G, Daly CJ, McGrath JC, MacDonald A.

Br J Pharmacol. 2005 Dec;146(7):942-51.

43.

Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.

Hillier CJ, Ware LA, Barbosa A, Angov E, Lyon JA, Heppner DG, Lanar DE.

Infect Immun. 2005 Apr;73(4):2109-15.

44.

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

Heppner DG Jr, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J.

Vaccine. 2005 Mar 18;23(17-18):2243-50. Review.

PMID:
15755604
45.

A comparison of biologically variable ventilation to recruitment manoeuvres in a porcine model of acute lung injury.

Funk DJ, Graham MR, Girling LG, Thliveris JA, McManus BM, Walker EK, Rector ES, Hillier C, Scott JE, Mutch WA.

Respir Res. 2004 Nov 24;5:22.

46.

Pharmacological characterization of alpha1-adrenoceptors in mouse isolated femoral small arteries.

Zacharia J, Hillier C, Macdonald A.

Eur J Pharmacol. 2004 Oct 25;503(1-3):155-63.

PMID:
15496310
47.

The clinical relevance of adrenomedullin: a promising profile?

Bunton DC, Petrie MC, Hillier C, Johnston F, McMurray JJ.

Pharmacol Ther. 2004 Sep;103(3):179-201. Review.

PMID:
15464589
48.

Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels.

Sainsbury CA, Sattar N, Connell JM, Hillier C, Petrie JR.

Clin Sci (Lond). 2004 Dec;107(6):625-9.

PMID:
15367101
49.

Aspergillosis of the petrous apex.

Rushton P, Battcock T, Denning A, Herbetko J, Hillier C, Nicholas D.

Age Ageing. 2004 May;33(3):317-9.

PMID:
15082443
50.

Supplemental Content

Loading ...
Support Center